Perk Pharmaceuticals Limited

Perk Pharmaceuticals Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN L24231UP1981PLC005400 Incorporated 24 August 1981 ROC Uttar Pradesh HQ Meerut, Uttar Pradesh, India
Active Listed Public Limited Company pharma
Revenue · FY 2020
₹15.71 Cr
▲ 208% YoY
Net profit · FY 2020
₹32.34 Lakh
Net margin 2.1%
EBITDA · FY 2020
₹28.62 Lakh
EBITDA margin 1.8%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹6.38 Cr
Issued & subscribed
Open charges
₹38.5 Lakh
Satisfied ₹6.36 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
9
Provident fund records

About Perk Pharmaceuticals Limited

Data last updated:

Perk Pharmaceuticals Limited is a public limited company based in Meerut, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 1981 and has been in existence for over 45 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN L24231UP1981PLC005400. It is recorded as listed by MCA, but its shares were delisted from BSE, and no longer trade on a stock exchange.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.38 Cr. It is led by directors including Krishna Kaile (Managing Director) and Ritu Kaile (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 7 Industrial Estate Partapur Meerut, Uttar Pradesh, India – 250103.

As per the financials filed for FY 2020, the company reported a revenue of ₹15.71 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.34 Lakh (net margin 2.1%) and EBITDA of ₹28.62 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 141% over three years and 77% over five years.

The company has about 9 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹38.5 Lakh and satisfied charges of ₹6.36 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 2 cases are pending.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website perkpharma.com.

Company details

CIN L24231UP1981PLC005400
Registration Number 005400
Incorporation Date 24 August 1981
ROC Uttar Pradesh
Listing Status Listed - Delisted from BSE
Company Status Active
Compliance Status Active Non-Compliant

CIN history

Perk Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231UP1981PLC005400. The current CIN is L24231UP1981PLC005400, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24231UP1981PLC005400Current
U24231UP1981PLC005400Previous

Contact details

Perk Pharmaceuticals Limited's registered office is in Meerut, Uttar Pradesh. Its website is perkpharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    A – 7 Industrial Estate Partapur Meerut, Uttar Pradesh, India – 250103
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Perk Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Perk Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Perk Pharmaceuticals Limited

FY 2025 filings available

Perk Pharmaceuticals Limited reported revenue of ₹15.71 Cr (up 208% YoY) for FY 2020.

Revenue · FY 2020
₹15.71 Cr ▲ 208%
Net profit · FY 2020
₹32.34 Lakh margin 2.1%
EBITDA · FY 2020
₹28.62 Lakh margin 1.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 208%
3 years · compounded
▲ 141%
5 years · compounded
▲ 77%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 27%
5 years · compounded
▲ 14%

Revenue has grown at a compounded annual rate (CAGR) of 77% over five years, including 208% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹15.71 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹28.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹32.34 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin1.8%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Perk Pharmaceuticals Limited, buy the company report.

Board of directors of Perk Pharmaceuticals Limited

Perk Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishna KaileManaging Director01 Oct 199333 Years 1 MonthsCurrent
Monica KaileDirector21 Oct 201511 Years 1 MonthsCurrent
Ritu KaileWhole-Time Director21 Oct 201511 Years 1 MonthsCurrent

Auditor

Perk Pharmaceuticals Limited is audited by JYOTSANA MADAN & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
JYOTSANA MADAN & ASSOCIATESFY 2019007483C

Shareholding

The shareholding of Perk Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Perk Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹38.5 Lakh
Satisfied charges
₹6.36 Cr
Breakdown by lending institutions
Union Bank of India₹0.37 Cr
Uno Bank of India₹0.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Aug 198790271154Uno Bank of India₹1.75 LakhOpen
05 Jan 198790268297Union Bank of India₹1.75 LakhOpen
05 Jan 198790271117Union Bank of India₹35 LakhOpen
10 Jun 199890267877The Pradeshiya Industrial & Investment Corporation of Ltd.₹3.18 CrSatisfied
25 May 199890269168The Pracieshiya Industrial & Investment Corporation of Ltd.₹3.18 CrSatisfied

To see the full charge records of Perk Pharmaceuticals Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Perk Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Perk Pharmaceuticals Limited has a workforce of 9 employees on its EPFO records as of Dec 2020, across 2 active EPFO establishments.

Employee count
9
Active EPFO establishments
2

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2020-219
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Perk Pharmaceuticals Limited, buy the company report.

GST

No GST registration is on our record for Perk Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Perk Pharmaceuticals Limited has 9 board changes on record since 1981: 6 appointments and 3 cessations. The latest: Dhiraj Kumar Kaile ceased to be Managing Director on 22 Oct 2015.

AGM
Perk Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Perk Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Dhiraj Kumar Kaile ceased to be Managing Director.
Ceased
Vikram Kaile ceased to be Director.
Appointed
Monica Kaile was appointed as Director.
Appointed
Ritu Kaile was appointed as Whole-Time Director.
Ceased
Ramesh Kumar Kaile ceased to be Managing Director.
Charges
A charge registered on 10 Jun 1998 via Charge ID 90267877 with The Pradeshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009.
Charges
A charge registered on 25 May 1998 via Charge ID 90269168 with The Pracieshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009.
Charges
A charge with Union Bank Of India of Rs. 0.35 Cr registered on 05 Jan 1987 with Charge ID 90271117 was modified on 26 May 2006.
Charges
A charge with The Pradeshiya Industrial & Investment Corporation Of Ltd. amounted to Rs. 3.18 Cr with Charge ID 90267877 was registered on 10 Jun 1998.
Charges
A charge with The Pracieshiya Industrial & Investment Corporation Of Ltd. amounted to Rs. 3.18 Cr with Charge ID 90269168 was registered on 25 May 1998.

9 earlier events are in the company report.

Frequently asked questions

Perk Pharmaceuticals is an active public limited company based in Meerut, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 1981 (45+ years old) and is registered under CIN L24231UP1981PLC005400.

Perk Pharmaceuticals has 3 current directors:

The latest financial statements of Perk Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Perk Pharmaceuticals is L24231UP1981PLC005400. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Perk Pharmaceuticals is recorded as a listed company by MCA, but its shares were delisted from BSE, and no longer trade on a stock exchange.

Perk Pharmaceuticals has 6 court cases on record: 6 filed against it. 2 are pending. Most are in the district courts.

Perk Pharmaceuticals was incorporated on 24 August 1981, making it 45+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Dhiraj Kumar Kaile ceased to be Managing Director on 22 Oct 2015. Vikram Kaile ceased to be Director on 22 Oct 2015. Monica Kaile was appointed as Director on 21 Oct 2015. Perk Pharmaceuticals has 9 board changes on record in total.

Perk Pharmaceuticals can be reached through the website perkpharma.com. Its registered office is in Meerut, Uttar Pradesh, India.

The registered office of Perk Pharmaceuticals is at A – 7 Industrial Estate Partapur Meerut, Uttar Pradesh, India – 250103.